Objective: The generation of distinct cell types during the development of the pancreas depends on sequential changes in gene expression. We tested the hypothesis that microRNAs (miRNAs), which limit gene expression through post-transcriptional silencing, modulate the gene expression cascades involved in pancreas development.
Pancreatic organogenesis begins at e9.5 in the mouse embryo with the budding of the dorsal anlagen from the prospective gut endoderm (1) . Pancreatic duodenal homeobox-1 (Pdx1) appears in the same area one day earlier, and is expressed in all pancreas progenitors (2; 3). As the pancreatic program continues, the expression of bHLH factor neurogenin3 initiates the differentiation of the endocrine cells.
Neurogenin3 expression peaks coincidently with the "secondary transition" -a time of rapid endocrine cell generation that occurs between e13.5 and e14.5 (4; 5). The cellspecific factors Onecut1, Tcf1, Tcf2 and Sox9 as well as the Notch signaling pathway regulate Neurog3 expression during development (5) (6) (7) (8) (9) .
Many tissues of the developing organism express miRNAs, which are small (~20 nt) RNAs that mediate posttranscriptional gene silencing by interacting with the RNA-induced silencing complex (RISC) and binding to the 3' untranslated region of their cognate mRNA targets (10; 11).
Here we hypothesize that miRNAs are expressed in the developing pancreas, that they are necessary for the normal development of pancreatic β-cells and that they may be involved in regulating genes important for normal pancreas morphogenesis. Ultimately, an intimate understanding of how miRNAs govern pancreas development may be necessary for stem cell based therapies for all forms of diabetes mellitus.
Research Design and Methods: Animals
Mice were housed on a 12-hr light-dark cycle in a controlled climate according to the University of California, San Francisco regulations. Timed matings were carried out with embryonic day 0.5 being set as midday of the day of discovery of a vaginal plug. Control mice in this study were double heterozygous for the Dicer1 (12) and Pdx1-Cre (3) alleles. CD-1 mice were obtained from Charles River Laboratories (Wilmington MA, USA).
Cloning of Small RNAs from the Developing Mouse Pancreas
118 embryos from 10 CD-1 mice were removed from pregnant mothers at e14.5 and embryonic pancreata was dissected and isolated from the spleen and other surrounding tissue. RNA was then isolated using Trizol and the manufacturer's protocols (Invitrogen, Carlsbad CA, USA) with the exception that the RNA pellet was not washed with 70% ethanol following isopropanol precipitation. We obtained 189 µg of RNA from 118 pancreata.
MiRNA cloning was carried out as previously described by Lau et al (13) ; briefly, linkers were then ligated onto the 3' and 5'-ends of size fractionated RNA, RNA was reverse-transcribed and amplified using PCR. The PCR products were restriction digested with BanI, concatermized with T4 DNA Ligase, and gel-purified fragments ranging from 600-800bp were TOPO cloned (Invitrogen). Plasmid DNA was isolated from 100 colonies and sequenced using M13 primers. Sequences were deconvolved using a Java applet that is available on request. Sequences were then aligned against the miRNAome (http://microrna.sanger.ac.uk/sequences/) and unknown sequences were aligned against genome.
Regions of high sequence homology were then folded using RNAshapes (14) and those that folded into hairpin loops were considered miRNAs.
Immunofluorescence analysis
Embryonic Morphometric analyses were done by serially sectioning the entire pancreas followed by staining and counting every 12th section for e18.5 embryos or every 8th section for e15.5 embryos. DAPI stained cell nuclei were counted using the cell counting application and cytoplasmic staining was quantified using the integrated metamorphic analysis: both in the Metamorph suite of programs (version 7, Molecular Devices; Union City, CA). Statistical analyses were done using Prism (version 4, Graphpad Software; San Diego, CA) and either T-tests or nonparametric Mann-Whitney U tests were used. P values of < 0.05 were considered statistically significant.
Locked Nucleic Acid In Situ Hybridization
Embryos (e14. Quantitative PCR Embryonic pancreas were harvested at e12.5 and immediately placed in 0.5ml of Trizol (Invitrogen) and RNA was extracted using the manufacturer's protocols. 250ng of total RNA was subjected to reverse transcription using random hexamers, Superscript III (Invitrogen) and the manufacturer's suggested reaction conditions. Complementary DNA was then amplified in quadruplicate using Taqman with an intron-spanning primer-probe set for Hes1 (Forward, AAG GCA GAC ATT CTG GAA ATG AC; Reverse, CGC GGT ATT TCC CCA ACA C; Probe, AGA TGA CCG CCG CGC TCA GC).
Hes1 expression was normalized to Taqman quantified mouse glucuronidase expression in the individual pancreatic cDNA samples (17) .
Results:
MicroRNA are expressed in the developing pancreas:
To determine their expression profile and identify novel miRNAs, small RNAs were cloned and sequenced from the pancreata of e14.5 mouse embryos using standard miRNA cloning and sequencing protocols (13) . In total, 107 known mouse miRNAs were cloned: 5 of which are evolutionarily conserved but had not previously been found in the mouse (Table 1) . Unknown sequences were then aligned with the genome and the surrounding, conserved genomic regions were folded into hairpins (Supplemental Table 1 available at http://diabetes.diabetesjournals.org). Using this approach, 18 novel mouse miRNAs were discovered, including some that lie in potential multicystronic miRNA transcripts (Supplemental Table 1 ). In addition, significant differences in a number of miRNA sequences were observed from those annotated in miRBase (18) . For example, multiple copies of mmu-miR-720 and mmu-miR-411 differed significantly from the sequences in miRBase (Table 1) . Differences identified in the 5' end of several miRNA are of particular significance, because the majority of miRNA target prediction algorithms rely on Watson-Crick base pairing of nucleotides 2 through 7 from the 5'-end of the miRNA; thus, 1 or 2 base pair differences at the 5' end could completely change the target profile of any miRNA (19; 20) .
Many of the miRNAs that were cloned here have not been previously detected at high levels in other tissues; therefore, we hypothesized that they might play specific roles in pancreas development. To assess the expression domain of these miRNAs during pancreas development, in situ hybridization with highly-specific locked-nucleic acid (LNA) probes was carried out for a few of these highly expressed miRNAs (Figure 1 ) (21) . We first tested mmu-miR-375 because it was overrepresented in our cloning experiment (Table 1) and has previously been demonstrated to be expressed in, and important for, pancreatic β-cell function. In situ analyses showed localization of miR-375 in the pancreatic ductal epithelium (i.e. the progenitor cells from which the endocrine and exocrine cells differentiate) at e14.5 ( Figures 1A&B) . Furthermore, Figure 1B demonstrates colocalization of miR-375 with Pdx1 in the e14.5 pancreas; thus, in addition to regulating insulin secretion in mature β-cells (22), miR-375 expressed in the progenitor cells may also be important during normal development. We also performed in situ analyses for three other overrepresented miRNAs. Both miR-503 and miR-541 were expressed in a similar pattern to miR-375 in progenitor cells in e14.5 pancreas, while miR-214 was expressed throughout the gut (Figures 1C-1H ).
MicroRNA expression is necessary for pancreas organogenesis
To determine the importance of miRNAs in pancreatic development, the second RNAse III domain of Dicer1 (3; 12) was conditionally ablated in all pancreatic cells starting at e9.5 using Pdx1-Cre-mediated deletion (3). Biogenesis of miRNAs requires the sequential activity of two ds-RNAspecific endonucleases, Drosha and Dicer1, that act in the nucleus and cytosol respectively (23) . In mammals, removal of the pre-miRNA hairpin loop by a single Dicer homolog is a prerequisite for interaction of the mature sequence with RISC. Therefore, loss of the RNAse III domain of Dicer1 blocks the formation of miRNAs (12; 24) .
The pancreas-specific Dicer1 knockout mice survived until birth but failed to grow and died by P3 ( Figures  2A&B) . Pancreata from e18.5 null mice had a dramatic reduction in the ventral pancreas, as well as a reduction in the overall epithelial contribution to the dorsal pancreas ( Figure 2D ). The remaining tissue in the Dicer1 null pancreata was comprised of clumps of disorganized epithelium interspersed with large vacuous areas and dilated ducts filled with impactions of debris (Figures 2F&H).
Early pancreatic miRNA expression is necessary for normal pancreatic cell differentiation
Cell-type specific antisera were utilized to determine the effects of Dicer1 loss on specific pancreatic lineages. Costaining of the e18.5 pancreas for synaptophysin, an endocrine marker, and the exocrine enzyme amylase revealed reductions in both the number of stained cells and the intensity of staining for both markers (Figures 3A&B). Immunoreactivity for the duct marker mucin1 remained unchanged in the knockout animal at this stage, but the debris filling the dilated ducts stained strongly for both mucin and amylase (arrow heads; Figures 3B&J) . Staining for specific hormones demonstrated a significant loss (94%; Figure 3K ) of insulin-producing β−cells in the knockout animals and 79%, 95%, and 86% losses of alpha, delta and PP cells respectively ( Figure 3K ), but no compensatory increase in ghrelin producing ε-cells ( Figures 3C-J) (25) . The differences in the reductions of the various endocrine cell types were significant, as demonstrated by significant changes in the ratios of distinct endocrine cell types in the Pdx-Cre Dicer1 flox/flox relative to their wildtype littermates (Figures  3L) . Pdx1 immunoreactivity, which is restricted predominantly to β−cells at this stage, was also decreased within e18.5 knockout pancreases (cf. Figures 3E&F) .
To distinguish between a role in β-cell genesis and in maintenance or proliferation of mature beta-cells, we also specifically removed Dicer1 from differentiated β-cells by crossing the Dicer1 flox mice with mice carrying a Cre allele driven by the rat insulin 2 (RIP2) promoter (26) (Figure 4 ). β-cell-specific Dicer1 knockout animals survived and their islets cells appeared morphologically normal at 8 months of age (c.f. Figures  4A&B) . In addition, to exclude the possibility that Dicer1 loss specifically impacts the maintenance or proliferation of mature β-cells in the embryo, β-cell counting was performed also at e18.5. Control and RIP2-Cre Dicer flox/flox animals at this developmental stage contained equal numbers of insulin-immunoreactive β-cells ( Figure 4C ). Finally we also conditionally ablated Dicer1 using a Neurogenin3-Cre transgene, which causes recombination in all endocrine cells. These animals also exhibit normal isletcell hormone staining at e18.5 (data not shown).
To identify the origins of the Pdx1-mediated Dicer deletion phenotypes that were observed at e18.5, earlier time points were examined. At e12.5 staining for Pdx1 and glucagon -markers of undifferentiated pancreatic epithelial progenitors and the earliest differentiated cells in the pancreas respectively -was not different between the mutant and wildtype pancreata (Figures  5A&B) . However, by e15.5 knockout embryos lacked Dicer1 immunoreactivity in the Pdx1 expressing cells (Supplemental Figure 1 ) and had significant reductions in pancreatic size and ductal branching ( Figures 5C-H) .
At this stage in development, Pdx1 antisera weakly stains the majority of cells lining the ducts and strongly stains the nascent β-cells, and neurogenin3 expression marks the committed endocrine progenitors. In the knockout animals, a decrease in the number of cells staining brightly for Pdx1 ( Figure 5D ) and a significant, 89%, reduction in neurogenin3 expressing cells was observed ( Figures 5D,F,H&I) , indicating a defect in the endocrine differentiation program. Ductal Pdx1 and mucin1 staining was not grossly altered in the Dicer1 null animals at e15.5 ( Figures  4D,H) .
MicroRNAs regulate the notch pathway and prevent programmed cell death during pancreatic development
Notch signaling inhibits the expression of neurogenin3 and thereby constrains endocrine differentiation in the developing pancreas in a manner analogous to lateral inhibition in the developing nervous system(5; 27; 28). The notch target gene Hes1 is expressed in the majority of early pancreatic epithelial cells and strongly represses Neurog3 gene transcription within those cells (8; 16) .
We hypothesized that specific miRNAs may activate endocrine differentiation by inhibiting components of the Notch signaling pathway: thereby relieving the constraint on neurogenin3 expression. We tested this hypothesis by assessing Hes1 expression using Taqman and found a modest increase in Hes1 mRNA (35%) at e12.5 ( Figure 6K ). Because Hes1 is expressed in the pancreatic mesenchyme as well as the Pdx1-expressing epithelium, and because Hes1 may be a target for translational regulation, we also stained e12.5 pancreas for Hes1 and observed an increase in Hes1 expression specifically within the Pdx1 expression domain in Dicer1 deficient pancreas ( Figure 6 ).
In addition to the loss of neurogenin3, starting at e15.5 there was an overall decrease in cells derived from the pancreatic epithelium in the knockout animals ( Figure 2 and data not shown). Since miRNAs can regulate apoptosis during organ development (12; 29; 30) , rates of programmed cell death and cell proliferation were assessed in the pancreatic specific Dicer1 knockout animal, using specific antisera for activated Caspase 3 and Ki-67 (MKi67) respectively.
A clearly significant increase (4.6-fold) was observed in total apoptotic cells at e15.5 in pancreases from knockout animals, and this increase appeared to be limited to the epithelial cells, as apoptosis was unchanged in the surrounding mesenchymal cells, which still expressed Dicer ( Figures 6H,I&J) . Cell proliferation was unchanged (Supplemental Figure 2 ; counting data not shown).
Discussion:
Here we demonstrated that the developing pancreas expresses a unique complement of miRNAs and that Dicer1, the enzyme that generates these miRNAs, is essential for normal pancreatic development. Many of the miRNAs that were highly expressed in the developing pancreas have not been previously cloned in high numbers or from specific tissues (e.g. miR-503 & miR-541).
High expression in the developing pancreas could suggest that these miRNAs play important roles in the developmental program; although, to date we have not identified any targets of these genes with known roles in pancreas development. In contrast, the novel miRNAs identified in this study all had fairly low expression levels as gauged by the number of clones obtained.
Despite their low overall abundance, these miRNAs could still play important roles at specific target genes or in cell types at low abundance in the e14.5 pancreas.
Although exocrine and duct cells were also affected, loss of miRNA processing uniquely impaired the development of the endocrine lineage, especially the β-and δ-cells. Two lines of evidence suggest that miRNAs are important for β-cell genesis rather than β-cell maintenance.
First, a dramatic reduction in the number of neurogenin3 positive endocrine progenitor cells from which all β-cells are derived was observed at e15.5. Consistent with a reduction in islet cell progenitors, glucagon, somatostatin and pancreatic polypeptide expressing endocrine cells were also reduced, although ghrelin expressing cells were not. The relatively less severe α-cell phenotype may be solely a timing issue, as Pdx1-mediated loss of Dicer1 may not be complete until after the first glucagon positive cells differentiate, and Pdx1 null animals do have glucagon positive cells (31) . Alternatively, miRNAs may act downstream of neurogenin3 to influence cell fate decisions, and in the absence of miRNAs the few remaining neurogenin3-expressing progenitors may preferentially differentiate into α-and ε-cells.
Secondly, when Dicer1 was ablated using the RIP2-Cre (or the Neurog3-Cre) transgene (Figure 4) we saw little effect on pancreatic islet cell morphology and no apparent effect on β-cell development ( Figure 4C ) or β-cell maintenance.
A previous study demonstrated that miR-375 normally constrains β-cell insulin secretion in a mytrophin dependent fashion (22) . Our data here focused on the role of miRNAs in the formation of β-cells are not at odds with these previous data on islet function. We have shown that islet and β-cell development remains unaffected in the RIP2-Cre Dicer1 flox/flox mice, but we have not directly tested the glucose-stimulated insulin secretory response of these islets.
It is possible that there could be a functional defect in the islets of these animals, although given the proposed inhibitory role of miR-375 on insulin secretion such defects might not result in glucose intolerance or overt diabetes. Furthermore, glucose metabolism defects might be confounded by the expression of the RIP2-Cre transgene in cells in the hypothalamus that also impact glucose metabolism (26) .
The large number of miRNAs expressed in the developing pancreas, and the large number of potential targets for each of these complicate the task of identifying the miRNAs that normally maintain neurogenin3 expression and endocrine cell generation, but the increase in the neurogenin3 inhibitor Hes1 suggests that Hes1 or upstream genes in the notch signaling pathway could be miRNA targets in pancreatic progenitor cells. Previous studies have implicated Hes1 protein as a target of miR-23a (32; 33), and miR-23a was expressed in the developing pancreas (Table1) (Although, this paper was withdrawn because the authors mistakenly used the wrong gene sequence for their analyses, the observation that miR-23a can influence the expression of Hes1 remains a possibility from this publication). In addition, it seems likely that miRNA may target other notch pathway components upstream of Hes1, yielding an increase in Hes1 expression in the absence of Dicer1. In summary, these data demonstrate for the first time that a unique set of miRNAs emerge during pancreas development and regulate pathways important for normal ductal, exocrine and endocrine development. Exploration of the roles of individual miRNA will provide a more complete understanding of pancreatic development and the differentiation of the distinct cell types, especially β−cells, and help in developing methods for generating these cells for therapeutic uses.
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